Shopping Cart 0
Cart Subtotal
AED 0

Texas Biomedical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program includes study on cardiovascular disease, diabetes, obesity, cancer, psychiatric disorders, liver disease, malaria, muscular dystrophy, fever viruses, AIDS, hepatitis, parasitic infections and neurodegenerative diseases. The institute also conducts research on genetics, virology and immunology. Texas Biomed is headquartered in San Antonio, Texas, the US.

Texas Biomedical Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Texas Biomedical Research Institute Enters into Research Contract with Mapp Biopharma 10

Mymetics Enters into Agreement with Texas Biomedical Research Institute 11

Southwest Research Institute Enters into Agreement with Texas Biomedical Research Institute 12

Texas Biomedical Research Institute-Key Competitors 13

Texas Biomedical Research Institute-Key Employees 14

Texas Biomedical Research Institute-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Jul 24, 2018: Research shows a promising new class of antibodies protects against HIV-1 infection 16

Jul 17, 2018: Tackling liver cancer using CRISPR to develop a new animal model-TXBioBytes Podcast Episode 013 17

Jun 22, 2018: Repurposing Promising Cancer Drugs May Lead to a New Approach to Treating TB 18

Dec 11, 2017: New Animal Model for Zika Developed at Texas Biomed Useful for Testing Vaccines and Treatments 19

Nov 22, 2017: Texas Biomedical Forum Announces 2017 Grant Recipients 20

Nov 15, 2017: Search for Novel Biomarkers Indicating Early Cardiovascular Disease Risk Wins Funding To Design Larger Scale Study in People of Mexican Ancestry 22

Nov 07, 2017: Promising new drug for Hep B tested at Texas Biomedical Research Institute 24

Oct 10, 2017: Researcher receives NIH grant to study biomarkers of variation in brain regions important to neuropsychiatric disorders 25

Sep 20, 2017: Texas Biomed Scientists part of USD 11.5 million NIH project aimed at combating drug resistance in the malaria parasite 26

Aug 21, 2017: Texas Biomed part of team receiving five-year, USD 4.4 million NIH grant for novel TB vaccine testing 27

Jan 25, 2017: Texas Biomed scientist receives 5-year, USD 4.6 million MERIT Award for malaria research 29

Product News 31

Aug 16, 2018: New Hepatitis B vaccine testing at Texas Biomed 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas Biomedical Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Texas Biomedical Research Institute Enters into Research Contract with Mapp Biopharma 10

Mymetics Enters into Agreement with Texas Biomedical Research Institute 11

Southwest Research Institute Enters into Agreement with Texas Biomedical Research Institute 12

Texas Biomedical Research Institute, Key Competitors 13

Texas Biomedical Research Institute, Key Employees 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Texas Biomedical Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program includes study on cardiovascular disease, diabetes, obesity, cancer, psychiatric disorders, liver disease, malaria, muscular dystrophy, fever viruses, AIDS, hepatitis, parasitic infections and neurodegenerative diseases. The institute also conducts research on genetics, virology and immunology. Texas Biomed is headquartered in San Antonio, Texas, the US.

Texas Biomedical Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Texas Biomedical Research Institute Enters into Research Contract with Mapp Biopharma 10

Mymetics Enters into Agreement with Texas Biomedical Research Institute 11

Southwest Research Institute Enters into Agreement with Texas Biomedical Research Institute 12

Texas Biomedical Research Institute-Key Competitors 13

Texas Biomedical Research Institute-Key Employees 14

Texas Biomedical Research Institute-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Jul 24, 2018: Research shows a promising new class of antibodies protects against HIV-1 infection 16

Jul 17, 2018: Tackling liver cancer using CRISPR to develop a new animal model-TXBioBytes Podcast Episode 013 17

Jun 22, 2018: Repurposing Promising Cancer Drugs May Lead to a New Approach to Treating TB 18

Dec 11, 2017: New Animal Model for Zika Developed at Texas Biomed Useful for Testing Vaccines and Treatments 19

Nov 22, 2017: Texas Biomedical Forum Announces 2017 Grant Recipients 20

Nov 15, 2017: Search for Novel Biomarkers Indicating Early Cardiovascular Disease Risk Wins Funding To Design Larger Scale Study in People of Mexican Ancestry 22

Nov 07, 2017: Promising new drug for Hep B tested at Texas Biomedical Research Institute 24

Oct 10, 2017: Researcher receives NIH grant to study biomarkers of variation in brain regions important to neuropsychiatric disorders 25

Sep 20, 2017: Texas Biomed Scientists part of USD 11.5 million NIH project aimed at combating drug resistance in the malaria parasite 26

Aug 21, 2017: Texas Biomed part of team receiving five-year, USD 4.4 million NIH grant for novel TB vaccine testing 27

Jan 25, 2017: Texas Biomed scientist receives 5-year, USD 4.6 million MERIT Award for malaria research 29

Product News 31

Aug 16, 2018: New Hepatitis B vaccine testing at Texas Biomed 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Texas Biomedical Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8

Texas Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Texas Biomedical Research Institute Enters into Research Contract with Mapp Biopharma 10

Mymetics Enters into Agreement with Texas Biomedical Research Institute 11

Southwest Research Institute Enters into Agreement with Texas Biomedical Research Institute 12

Texas Biomedical Research Institute, Key Competitors 13

Texas Biomedical Research Institute, Key Employees 14

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Texas Biomedical Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.